Company: CERO
Filing Date: 2025-04-28
Form Type: 10-K/A
Source: 0001213900-25-036075
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-28
Form: 10-K/A
Chunk 3
---
 not required to be included with Amendment No. 1. Except as otherwise expressly noted herein, this Amendment No. 1 does not amend any other information set forth in the Original Annual Report, and we have not updated disclosures contained therein to reflect any events that occurred at a date subsequent to the date of the filing of the Original Annual Report. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Annual Report and our other filings with the SEC. Certain capitalized terms used and not otherwise defined in this Amendment No. 1 have the meanings given to them in the Original Annual Report. CERO THERAPEUTICS HOLDINGS, INC. TABLE OF CONTENTS

|            |                                                                                                | Page |
| PART III   |                                                                                                |    1 |
| Item 10.   | Directors, Executive Officers and Corporate Governance                                         |    1 |
| Item 11.   | Executive Compensation                                                                         |   11 |
| Item 12.   | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |   20 |
| Item 13.   | Certain Relationships and Related Transactions, and Director Independence                      |   21 |
| Item 14.   | Principal Accountant Fees and Services                                                         |   23 |
| PART IV    |                                                                                                |   24 |
| Item 15.   | Exhibits, Financial Statement Schedules                                                        |   24 |
| SIGNATURES |                                                                                                |   29 |

i PART III Item 10. Directors, Executive Officers and Corporate Governance Directors Our board of directors (the “Board”) currently consists of six members. In accordance with the terms of our Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) and Amended and Restated Bylaws (the “Bylaws”), the Board is divided into three classes, Class I, Class II and Class III, with members of each class serving staggered three-year terms. The members of the classes are divided as follows:

| ● | the Class I directors are Mr. Byrnes and Dr. Rolfe, and their terms will expire at our 2025 annual meeting of stockholders;; |

| ● | the Class II directors are Mr. Atwood and Ms. LaPorte, and their terms will expire at our 2026 annual meeting of stockholders; 
 and                                                                                                                            |

| ● | the Class III directors are Mr. Ehrlich and Mr. Patel, and their terms will expire at our 202